Picture of Fuso Pharmaceutical Industries logo

4538 Fuso Pharmaceutical Industries Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Annual income statement for Fuso Pharmaceutical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue46,07446,90149,25149,63251,015
Cost of Revenue
Gross Profit13,43012,80014,10913,39713,740
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses44,83345,95346,91147,79348,819
Operating Profit1,2419482,3401,8392,196
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes1,2551,0422,3451,9112,205
Provision for Income Taxes
Net Income After Taxes8947071,6081,4841,606
Net Income Before Extraordinary Items
Net Income8947071,6081,4841,606
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income8947071,6071,4831,605
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS10482.4177177184
Dividends per Share